- Home
- PHAR vs CWH Comparison
PHAR vs CWH Comparison
Compare PHAR & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAR | CWH |
|---|---|---|
| Founded | 1988 | 1966 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | PHAR | CWH |
|---|---|---|
| Price | $16.39 | $10.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $30.00 | $18.11 |
| AVG Volume (30 Days) | 21.0K | ★ 1.9M |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 4.83% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $362,274,000.00 | ★ $6,400,054,000.00 |
| Revenue This Year | $24.80 | $5.30 |
| Revenue Next Year | $6.84 | $5.00 |
| P/E Ratio | $3,084.39 | ★ N/A |
| Revenue Growth | ★ 26.78 | 6.58 |
| 52 Week Low | $7.50 | $9.49 |
| 52 Week High | $18.12 | $24.37 |
Technical Indicators
Market Signals| Indicator | PHAR | CWH |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 37.64 |
| Support Level | $15.76 | $9.94 |
| Resistance Level | $18.12 | $11.05 |
| Average True Range (ATR) | 0.83 | 0.52 |
| MACD | -0.12 | 0.06 |
| Stochastic Oscillator | 28.81 | 13.85 |
Price Performance
Historical ComparisonAbout PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About CWH Camping World Holdings Inc.
Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.